Oklahoma got $270 million from Purdue to fix opioid crisis. its next target: Johnson & Johnson
HuffPost: Andrew Pollis, professor of law, speculated as to why Johnson & Johnson is trying to avoid litigation from Oklahoma over the opioid crisis, commenting that the optics of the case are detrimental to the company.
